会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • INDOLINE DERIVATIVES HAVING AN AMIDE FUNCTION, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    • 具有酰胺官能团的吲哚衍生物,其制备物和含有它们的药物组合物
    • WO1993003013A1
    • 1993-02-18
    • PCT/FR1992000758
    • 1992-07-31
    • ELF SANOFI
    • ELF SANOFIWAGNON, JeanPLOUZANE, ClaudeSERRADEIL-LEGAL, ClaudineNISATO, DinoTONNERRE, Bernard
    • C07D209/42
    • C07D401/06C07D209/42C07D401/12C07D403/06C07D417/06
    • The invention relates to compounds of formula (I), wherein R1 is a halogen atom, C1-C4 alkyl, hydroxyl, C1-C4 alkoxy, a group benzyloxy, cyano, trifluoromethyl, nitro or amino; R2 is C1-C6 alkyl, C3-C7 cycloalkyl, C5-C7 cycloalcen, a phenyl unsubstituted or substituted one or a plurality of times, C1-C4 alkoxy, halogen, a group trifluoromethyl, a group amino, or R2 is a nitrophenyl unsubstituted or substituted one or a plurality of times; R3 is a hydrogen atom; R4 is a carbamyl group having the formula CONR6R7; R5 is C1-C4 alkyl; naphtyl-1; naphtyl-2; dimethylamino-5 naphtyl-1; a phenyl unsubstituted or substituted one or a plurality of times, or R5 is nitrophenyl unsubstituted or substituted one or a plurality of times; R6 is C1-C6 alkyl, or R6 is similar to R7; R7 is a group piperidin-4-yl; a group azetidin-3-yl, said groups being substituted or unsubstituted on the nitrogen by C1-C4 alkyl, by a benzyloxycarbonyl or by an alkoxycarbonyl in C1-C4; a group (CH2)r itself substituted by a group pyridyl-2, -3 or -4, by a group hydroxyl, by an amino group free or substituted by one or two substituants; or R6 and R7 form together with the nitrogen atom to which they are linked a heterocycle selected amongst: morpholin, thiomorpholin, thiazolidin or 2,2-dimethylthiazolidin unsubstituted or substituted by R8, piperazin unsubstituted or substituted in 4 by a group R''8, an unsaturated mononitrogenated cycle with 5 links substituted by R8 or a saturated mononitrogenated cycle with 3, 4, 5, 6 or 7 links substituted by R8 and R9; R8 is R'8 or a group (CH2)r itself substituted by hydroxyl or by a free amino or substituted by one or two C1-C4 alkyls; R'8 is a group (CH2)q itself substituted by a carboxyl group, a group C1-C4 alkoxycarbonyl, a benzyloxycarbonyl group, a group carbamoyl free or substituted by a hydroxyl or by one or two C1-C4 alkyls, or a group aminocarbothioyl free or substituted by one or two C1-C4 alkyls; R''8 is R'8 or a group (CH2)2NH2 free or substituted by one or two C1-C4; R9 is hydrogen, halogen, a group (CH2)rOR10, a group (CH2)rNR11R12, a group (CH2)sCONR11R'11, a group azido; R10 is hydrogen, C1-C4 alkyl, mesyl or tosyl; R11, R'11 and R12 are each hydrogen or C1-C4 alkyl or R11 is hydrogen and R12 is C1-C4 alkoxycarbonyl or benzyloxycarbonyl; n is 0, 1 or 2; m is 0, 1, or 2; q is 0, 1, 2 or 3; r is 0, 1, 2 or 3 with the provision that r is different from 0 when R8 or R9 is in the alpha position of the intracyclic amidic nitrogen; s is 0 or 1; as well as its optional salts. These compounds are useful in the treatment of affections of the central nervous system, the cardiovascular system and the gastric system in human beings and animals.